Amyloid β-peptide induces apoptosis-related events in synapses and dendrites

Brain Research

Volumn 807, Issue 1-2, 1998, Pages 167-176

  Mattson, Mark P ^a   Partin, James ^a   Begley, J G ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease; Caspase; Dendritic spine; Mitochondrial transmembrane potential; Oxidative stress; Phosphatidylserine; Synaptosome

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; ARTICLE; DENDRITE; EMBRYO; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPSE; SYNAPTOSOME;

AMYLOID BETA-PROTEIN; ANIMALS; APOPTOSIS; CELL-FREE SYSTEM; CELLS, CULTURED; CEREBRAL CORTEX; DENDRITES; FEMALE; HIPPOCAMPUS; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; SYNAPSES; SYNAPTOSOMES;

EID: 0032487648     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00763-X     Document Type: Article

References (66)

1. Ankarcrona M., Dypbukt J.M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S.A., Nicotera P. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron. 15:1995;961-973.
2. 2+ channel blockers verapamil and nifedipine inhibit apoptosis induced by 25-hydroxycholesterol in human aortic smooth muscle cells. J. Lipid Res. 38:1997;2049-2061.
3. Armstrong R.C., Aja T.J., Hoang K.D., Gaur S., Bai X., Alnemri E.S., Litwack G., Karanewsky D.S., Fritz L.C., Tomaselli K.J. Activation of the CED3/ICE-related protease CPP32 in cerebellar granule neurons undergoing apoptosis but not necrosis. J. Neurosci. 17:1997;553-562.
4. Beal M.F. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol. 31:1992;119-130.
5. Blanc E.M., Toborek M., Mark R.J., Hennig B., Mattson M.P. Amyloid β-peptide disrupts barrier and transport functions and induces apoptosis in vascular endothelial cells. J. Neurochem. 68:1997;1870-1881.
6. Boldin M.P., Goncharov T.M., Goltsev Y.V., Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell. 85:1996;803-815.
7. Bredesen D.E. Neural apoptosis. Ann. Neurol. 38:1995;839-851.
8. Bruce-Keller A.J., Begley J.G., Fu W., Butterfield D.A., Bredesen D.E., Hutchins J.B., Hensley K., Mattson M.P. Bcl-2 protects isolated plasma and mitochondrial membranes against lipid peroxidation induced by hydrogen peroxide and amyloid β-peptide. J. Neurochem. 70:1997;31-39.
9. Cotman C.W., Taylor D. Isolation and structural studies on synaptic complexes from rat brain. J. Cell Biol. 55:1972;696-711.
10. DeKosky S.T., Scheff S.W., Styren S.D. Structural correlates of cognition in dementia: quantification and assessment of synapse change. Neurodegeneration. 5:1996;417-421.
11. DiPatre P.L., Gelman B.B. Microglial cell activation in aging and Alzheimer disease: partial linkage with neurofibrillary tangle burden in the hippocampus. J. Neuropathol. Exp. Neurol. 56:1996;143-149.
12. Du Y., Bales K.R., Dodel R.C., Hamilton-Byrd E., Horn J.W., Czilli D.L., Simmons L.K., Ni B., Paul S.M. Activation of a caspase 3-related cysteine protease is required for glutamate-mediated apoptosis of cultured cerebellar granule neurons. Proc. Natl. Acad. Sci. USA. 94:1997;11657-11662.
13. Ellerby H.M., Martin S.J., Ellerby L.M., Naiem S.S., Rabizadeh S., Salvesen G.S., Casiano C.A., Cashman N.R., Green D.R., Bredesen D.E. Establishment of a cell-free system of neuronal apoptosis: comparison of premitochondrial, mitochondrial, and postmitochondrial phases. J. Neurosci. 17:1997;6165-6178.
14. Estus S., Tucker H.M., van Rooyen C., Wright S., Brigham E.F., Wogulis M., Rydel R.E. Aggregated amyloid-β protein induces cortical neuronal apoptosis and concomitant 'apoptotic' pattern of gene induction. J. Neurosci. 17:1997;7736-7745.
15. Goodman Y., Mattson M.P. Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide-induced oxidative injury. Exp. Neurol. 128:1994;1-12.
16. Guo Q., Christakos S., Robinson N., Mattson M.P. Calbindin blocks the pro-apoptotic actions of mutant presenilin-1: reduced oxidative stress and preserved mitochondrial function. Proc. Natl. Acad. Sci. USA. 95:1998;3227-3232.
17. Gurtu V., Kain S.R., Zhang G. Fluorometric and colorimetric detection of caspase activity associated with apoptosis. Anal. Biochem. 251:1997;98-102.
18. Harvey N.L., Butt A.J., Kumar S. Functional activation of Nedd2/ICH-1 (Caspase-2) is an early process in apoptosis. J. Biol. Chem. 272:1997;13134-13139.
19. Houenou L.J., Li L., Lo A.C., Yan Q., Oppenheim R.W. Naturally occurring and axotomy-induced motoneuron death and its prevention by neurotrophic agents: a comparison between chick and mouse. Prog. Brain Res. 102:1994;217-226.
20. Irizarry M.C., Soriano F., McNamara M., Page K.J., Schenk D., Games D., Hyman B.T. Aβ deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J. Neurosci. 17:1997;7053-7059.
21. Iwasaki K., Sunderland T., Kusiak J.W., Wolozin B. Changes in gene transcription during a β-mediated cell death. Mol. Psychiatry. 1:1996;65-71.
22. Jacobson M.D., Burne J.F., Raff M.C. Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J. 13:1994;1899-1910.
23. Jesberger J.A., Richardson J.S. Oxygen free radicals and brain dysfunction. Int. J. Neurosci. 57:1991;1-17.
24. Jordan J., Galindo M.F., Miller R.J. Role of calpain- and interleukin-1β converting enzyme-like proteases in the β-amyloid-induced death of rat hippocampal neurons in culture. J. Neurochem. 68:1997;1612-1621.
25. Keller J.N., Mark R.J., Bruce A.J., Blanc E.M., Rothstein J.D., Uchida K., Mattson M.P. 4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes. Neuroscience. 80:1997;685-696.
26. Keller J.N., Kindy M.S., Holtsberg F.W., St. Clair D.K., Yen H.-C., Germeyer A., Steiner S.M., Bruce-Keller A.J., Hutchins J.B., Mattson M.P. Mitochondrial MnSOD prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation and mitochondrial dysfunction. J. Neurosci. 18:1998;687-697.
27. Keller J.N., Guo Q., Holtsberg F.W., Bruce-Keller A.J., Mattson M.P. Increased sensitivity to mitochondrial toxin-induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production. J. Neurosci. 18:1998;4439-4450.
28. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275:1997;1132-1136.
29. Kroemer G., Zamzami N., Susin S.A. Mitochondrial control of apoptosis. Immunol. Today. 18:1997;44-51.
30. Kruman I., Bruce-Keller A.J., Bredesen D.E., Waeg G., Mattson M.P. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci. 17:1997;5089-5100.
31. Kruman I., Guo Q., Mattson M.P. Calcium and reactive oxygen species mediate staurosporine-induced mitochondrial dysfunction and apoptosis in PC12 cells. J. Neurosci. Res. 51:1998;293-308.
32. Loo D.T., Copani A., Pike C.J., Whittemore E.R., Walencewicz A.J., Cotman C.W. Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. USA. 90:1993;7951-7955.
33. Mancini M., Nicholson D.W., Roy S., Thornberry N.A., Peterson E.P., Casciola-Rosen L.A., Rosen A. The caspase-3 precursor has a cytosolic and mitochondrial distribution: implications for apoptotic signaling. J. Cell Biol. 140:1998;1485-1495.
34. Margolin N., Raybuck S.A., Wilson K.P., Chen W., Fox T., Gu Y., Livingston D.J. Substrate and inhibitor specificity of interleukin-1 β-converting enzyme and related caspases. J. Biol. Chem. 272:1997;7223-7228.
35. 2+ homeostasis and cell death. J. Neurosci. 15:1995;6239-6249.
36. Martin L.J., Pardo C.A., Cork L.C., Price D.L. Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex. Am. J. Pathol. 145:1994;1358-1381.
37. Masliah E. Mechanisms of synaptic dysfunction in Alzheimer's disease. Histol. Histopathol. 10:1995;509-519.
38. Mattson M.P., Zhang Y., Bose S. Growth factors prevent mitochondrial dysfunction, loss of calcium homeostasis, and cell injury, but not ATP depletion in hippocampal neurons deprived of glucose. Exp. Neurol. 121:1993;1-13.
39. Mattson M.P., Tomaselli K., Rydel R.E. Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF. Brain Res. 621:1993;35-49.
40. Mattson M.P. Secreted forms of β-amyloid precursor protein modulate dendrite outgrowth and calcium responses to glutamate in cultured embryonic hippocampal neurons. J. Neurobiol. 25:1994;439-450.
41. Mattson M.P. Cellular actions of β-amyloid precursor protein, and its soluble and fibrillogenic peptide derivatives. Physiol. Rev. 77:1997;1081-1132.
42. Mattson M.P., Keller J.N., Begley J.G. Evidence for synaptic apoptosis. Exp. Neurol. 151:1998;. in press.
43. Nicotera P., Ankarcrona M., Bonfoco E., Orrenius S., Lipton S.A. Neuronal necrosis and apoptosis: two distinct events induced by exposure to glutamate or oxidative stress. Adv. Neurol. 72:1997;95-101.
44. Paradis E., Douillard H., Koutroumanis M., Goodyer C., LeBlanc A. Amyloid β peptide of Alzheimer's disease downregulates Bcl-2 and upregulates bax expression in human neurons. J. Neurosci. 16:1996;7533-7539.
45. Portera-Cailliau C., Hedreen J.C., Price D.L., Koliatsos V.E. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J. Neurosci. 15:1995;3775-3787.
46. Richter C. Pro-oxidants and mitochondrial calcium: their relationship to apoptosis and oncogenesis. FEBS Lett. 325:1993;104-107.
47. Rimon G., Bazenet C.E., Philpott K.L., Rubin L.L. Increased surface phosphatidylserine is an early marker of neuronal apoptosis. J. Neurosci. Res. 48:1997;563-570.
48. Sakahira H., Enari M., Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature. 391:1998;96-99.
49. Savill J. Recognition and phagocytosis of cells undergoing apoptosis. Br. Med. Bull. 53:1997;491-508.
50. Schubert W., Prior R., Weidemann A., Dircksen H., Multhaup G., Masters C.L., Beyreuther K. Localization of Alzheimer βA4 amyloid at presynaptic terminals. Brain Res. 563:1991;184-194.
51. Smith M.A., Hirai K., Hsiao K., Pappolla M.A., Harris P.L.R., Siedlak S.L., Tabaton M., Perry G. Amyloid deposition in Alzheimer transgenic mice Is associated with oxidative stress. J. Neurochem. 70:1998;2212-2215.
52. Su J.H., Anderson A.J., Cummings B., Cotman C.W. Immunocytochemical evidence for apoptosis in Alzheimers disease. NeuroReport. 5:1994;2529-2533.
53. Susin S.A., Zamzami N., Castedo M., Hirsch T., Marchetti P., Macho A., Kroemer G. Bcl-2 inhibits the mitochondrial release of apoptogenic protease. J. Exp. Med. 184:1996;1331-1341.
54. Susin S.A., Zamzami N., Castedo M., Daugas E., Wang H.G., Geley S., Fassy F., Reed J.C., Kroemer G. The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/CD95- and ceramide-induced apoptosis. J. Exp. Med. 186:1997;25-37.
55. Takadera T., Ohyashiki T. Apoptotic cell death and caspase 3 (CPP32) activation induced by calcium ionophore at low concentrations and their prevention by nerve growth factor in PC12 cells. Eur. J. Biochem. 249:1997;8-12.
56. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30:1991;572-580.
57. van Engeland M., Nieland L.J., Ramaekers F.C., Schutte B., Reutelingsperger C.P. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry. 31:1998;1-9.
58. Waring P., Beaver J. Cyclosporin A rescues thymocytes from apoptosis induced by very low concentrations of thapsigargin: effects on mitochondrial function. Exp. Cell Res. 227:1996;264-276.
59. 2+ channel blockers attenuate β-amyloid peptide toxicity to cortical neurons in culture. J. Neurochem. 62:1994;372-375.
60. Whittaker V.P. Thirty years of synaptosome research. J. Neurocytol. 22:1993;735-742.
61. Wyllie A.H., Kerr J.F.R., Currie A.R. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68:1990;251-306.
62. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., Peng T.I., Jones D.P., Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 275:1997;1129-1132.
63. Yankner B.A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron. 16:1996;921-932.
64. Yuan J. Transducing signals of life and death. Curr. Opin. Cell Biol. 9:1997;247-251.
65. Zamzami N., Marchetti P., Castedo M., Decaudin D., Macho A., Hirsch T., Susin S., Petit P., Mignotte B., Kroemer G. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182:1995;367-377.
66. Zamzami N., Marchetti P., Castedo M., Hirsch T., Susin S.A., Masse B., Kroemer G. Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis. FEBS Lett. 384:1996;53-57.